Report cover image

North America Digital PCR and Real-Time PCR Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949618

Description

The North America Digital PCR and Real-Time PCR Market is projected to grow significantly, reaching approximately US$ 6,712.8 million by 2031, up from US$ 3,806.2 million in 2024, with an estimated compound annual growth rate (CAGR) of 8.5% from 2025 to 2031.

Executive Summary and Market Analysis

The North American market for digital PCR and real-time PCR is experiencing rapid growth, primarily due to the increasing demand for advanced molecular diagnostics in areas such as cancer detection, infectious disease testing, and genetic research. The region's robust healthcare infrastructure, substantial government funding, and ongoing advancements in biotechnology have positioned it as a global leader in PCR technology adoption. A key driver of this market expansion is the rising incidence of cancer. According to the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed in the US in 2022, resulting in 609,360 deaths. PCR technology is crucial for early cancer detection, identifying genetic mutations, and monitoring treatment responses, all of which are essential for improving patient survival rates.

The demand for high-sensitivity tests, particularly liquid biopsies utilizing digital PCR (dPCR), has increased significantly, enabling the detection of rare mutations in blood samples through non-invasive methods. Additionally, the COVID-19 pandemic underscored the importance of rapid and accurate testing, leading to increased use of PCR in infectious disease diagnostics. Hospitals and diagnostic laboratories are investing in point-of-care (PoC) PCR devices for quicker disease detection in emergency and remote settings. Furthermore, pharmaceutical and biotech companies are incorporating PCR into drug development and personalized medicine, using its precision to identify biomarkers and customize treatments for patients. While quantitative PCR (qPCR) remains the dominant technology, dPCR is gaining traction due to its superior accuracy in detecting low-abundance DNA and RNA sequences, making it valuable in rare disease research, forensic testing, and environmental monitoring.

Despite the advantages, challenges such as high equipment costs, complex regulatory approvals, and the need for specialized training have hindered broader adoption. A dPCR system can cost over US$ 100,000, which may be prohibitive for smaller laboratories and research centers. Nevertheless, North America continues to lead the global digital PCR and real-time PCR market, driven by innovative research, increasing automation, and the growing use of AI-powered data analysis. As the healthcare sector shifts towards more personalized and precision-driven treatments, PCR technology will remain pivotal in providing faster and more reliable diagnostic solutions that enhance patient outcomes.

Strategic Insights

Market Segmentation Analysis
  • By Product and Services: The market is divided into Instruments, Reagents and Consumables, and Software and Services, with Reagents and Consumables holding the largest market share in 2024.
  • By Applications: The market is categorized into Infectious Diseases Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Others, with Infectious Diseases Testing leading in market share in 2024.
  • By End User: Segmented into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories, with Hospitals and Diagnostic Centers holding the largest share in 2024.
  • By Type: The market is split into Digital PCR and Real-Time PCR, with Real-Time PCR dominating in 2024.
Market Outlook

Droplet digital PCR (ddPCR) is an innovative technique that employs water-oil emulsion droplet technology, allowing a sample to be divided into approximately 20,000 droplets for amplification of target DNA strands. This method enables precise and absolute quantification of nucleic acid targets, facilitating extensive applications in diagnostics and research. Unlike qPCR, which relies on cycle threshold (CT) for DNA quantification and requires external calibrators, ddPCR counts target DNA directly without needing a calibration curve. This advancement is expected to significantly influence the future of the digital PCR and real-time PCR market.

Country Insights

The North American market is primarily segmented into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. The US leads in the adoption of digital PCR and real-time PCR, supported by a strong healthcare system, advanced research capabilities, and significant investments from both government and private sectors. For instance, the federal government allocated US$ 1.9 trillion to healthcare programs in fiscal year 2024, which is crucial for the adoption of PCR technologies in genetic testing, oncology, and infectious disease diagnostics. Key organizations like the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) play vital roles in funding and regulating PCR diagnostics, ensuring high standards for clinical applications.

Despite its leadership, the US market faces challenges related to regulatory complexities and high costs associated with dPCR platforms and consumables, which can limit access for smaller diagnostic labs. However, ongoing efforts to develop cost-effective, high-throughput solutions are anticipated to promote wider adoption.

The US digital PCR and real-time PCR market is expected to continue its growth trajectory, driven by innovations in personalized medicine, AI-enhanced diagnostics, and decentralized testing solutions. With sustained investment in biotechnology, infectious disease preparedness, and genomic research, the US will maintain its position as a global leader in PCR technology development and application.

Company Profiles

Key players in the North America Digital PCR and Real-Time PCR Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Agilent Technologies Inc, Takara Bio Inc, Danaher Corp, and Countable Labs. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. North America Digital PCR and Real-Time PCR Market - Key Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Digital PCR and Real-Time PCR Market - North America Market Analysis
5.1 North America Digital PCR and Real-Time PCR Market Revenue (US$ Million), 2024 - 2031
5.2 North America Digital PCR and Real-Time PCR Market Forecast and Analysis
6. North America Digital PCR and Real-Time PCR Market Revenue Analysis - by Product And Services
6.1 Instruments
6.1.1 Overview
6.1.2 Instruments: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Reagents and Consumables
6.2.1 Overview
6.2.2 Reagents and Consumables: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Software and Services
6.3.1 Overview
6.3.2 Software and Services: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. North America Digital PCR and Real-Time PCR Market Revenue Analysis - by Applications
7.1 Infectious Diseases Testing
7.1.1 Overview
7.1.2 Infectious Diseases Testing: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Oncology Testing
7.2.1 Overview
7.2.2 Oncology Testing: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Blood Screening
7.3.1 Overview
7.3.2 Blood Screening: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Transplant Diagnostics
7.4.1 Overview
7.4.2 Transplant Diagnostics: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. North America Digital PCR and Real-Time PCR Market Revenue Analysis - by End User
8.1 Hospitals and Diagnostic Centers
8.1.1 Overview
8.1.2 Hospitals and Diagnostic Centers: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Research Laboratories and Academic Institutes
8.2.1 Overview
8.2.2 Research Laboratories and Academic Institutes: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Pharmaceutical and Biotechnology Companies
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Companies: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Clinical Research Organizations
8.4.1 Overview
8.4.2 Clinical Research Organizations: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Forensic Laboratories
8.5.1 Overview
8.5.2 Forensic Laboratories: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. North America Digital PCR and Real-Time PCR Market Revenue Analysis - by Type
9.1 Digital PCR
9.1.1 Overview
9.1.2 Digital PCR: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Real-time PCR
9.2.1 Overview
9.2.2 Real-time PCR: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. North America Digital PCR and Real-Time PCR Market - Country Analysis
10.1 North America
10.1.1 North America Digital PCR and Real-Time PCR Market Revenue and Forecast and Analysis - by Country
10.1.1.1 North America Digital PCR and Real-Time PCR Market Revenue and Forecast and Analysis - by Country
10.1.2.2 United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 United States: North America Digital PCR and Real-Time PCR Market Share - by Product And Services
10.1.2.2.2 United States: North America Digital PCR and Real-Time PCR Market Share - by Applications
10.1.2.2.3 United States: North America Digital PCR and Real-Time PCR Market Share - by End User
10.1.2.2.4 United States: North America Digital PCR and Real-Time PCR Market Share - by Type
10.2.3.3 Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Canada: North America Digital PCR and Real-Time PCR Market Share - by Product And Services
10.2.3.3.2 Canada: North America Digital PCR and Real-Time PCR Market Share - by Applications
10.2.3.3.3 Canada: North America Digital PCR and Real-Time PCR Market Share - by End User
10.2.3.3.4 Canada: North America Digital PCR and Real-Time PCR Market Share - by Type
10.3.4.4 Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 Mexico: North America Digital PCR and Real-Time PCR Market Share - by Product And Services
10.3.4.4.2 Mexico: North America Digital PCR and Real-Time PCR Market Share - by Applications
10.3.4.4.3 Mexico: North America Digital PCR and Real-Time PCR Market Share - by End User
10.3.4.4.4 Mexico: North America Digital PCR and Real-Time PCR Market Share - by Type
11 Industry Landscape
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Other Strategic Developments
11 COMPANY PROFILES
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Thermo Fisher Scientific Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 bioMerieux SA
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bio-Rad Laboratories Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Agilent Technologies Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Takara Bio Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Danaher Corp
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Countable Labs
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Digital PCR and Real-Time PCR Market Segmentation
Table 3. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product And Services
Table 5. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 6. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product And Services
Table 10. United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 11. United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 13. Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product And Services
Table 14. Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 15. Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 16. Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 17. Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product And Services
Table 18. Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Applications
Table 19. Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 21. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. North America Digital PCR and Real-Time PCR Market Segmentation - Country
Figure 4. North America Digital PCR and Real-Time PCR Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Digital PCR and Real-Time PCR Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Digital PCR and Real-Time PCR Market Share (%) - by Product And Services, 2024 and 2031
Figure 8. Instruments: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Reagents and Consumables: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Software and Services: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. North America Digital PCR and Real-Time PCR Market Share (%) - by Applications, 2024 and 2031
Figure 12. Infectious Diseases Testing: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Oncology Testing: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Blood Screening: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Transplant Diagnostics: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Digital PCR and Real-Time PCR Market Share (%) - by End User, 2024 and 2031
Figure 18. Hospitals and Diagnostic Centers: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Research Laboratories and Academic Institutes: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Clinical Research Organizations: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Forensic Laboratories: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Digital PCR and Real-Time PCR Market Share (%) - by Type, 2024 and 2031
Figure 24. Digital PCR: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Real-time PCR: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. North America Digital PCR and Real-Time PCR Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 27. United States: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Canada: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Mexico: North America Digital PCR and Real-Time PCR Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us